New Therapeutic Developments for Relapsed/Refractory Multiple Myeloma

In this online program, experts discuss how to best use new therapeutic agents for patients with relapsed/refractory multiple myeloma. Watch the on-demand Webcast and download the slides from a dynamic online live CCO symposium, plus access expert commentaries and a podcast on the new data to learn more about how to select optimal regimens for your patients with advanced myeloma.
person default
Paula Rodriguez-Otero, MD, PhD
Jesús F. San-Miguel, MD, PhD
person default
Prof. Dr. med. Katja Weisel

Downloadable Slidesets

Download these slides to review expert insights on available treatments for patients with early relapsed, refractory MM

Jesús F. San-Miguel, MD, PhD Released: July 15, 2020

Download these slides to review expert insights on available treatments for patients with late relapsed, refractory MM.

person default Paula Rodriguez-Otero, MD, PhD Released: July 16, 2020

Download these slides to review expert insights on novel agents with new targets for patients with relapsed, refractory MM.

person default Prof. Dr. med. Katja Weisel Released: July 20, 2020
Provided by Clinical Care Options, LLC, in partnership with Clinical Care Options Global B.V.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
GlaxoSmithKline

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?